MZT2A serves as a prognostic biomarker and promotes the progression of kidney renal clear cell carcinoma
Abstract MZT2A is a novel core component in the γ-tubulin ring complex and aberrantly expressed in some types of tumors.…
Abstract MZT2A is a novel core component in the γ-tubulin ring complex and aberrantly expressed in some types of tumors.…
Abstract Background: Synonymous mutations have been identified to play important roles in cancer development, although they do not modify the…